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Introduction
Neurological complications of carcinoid tumours are gener-
ally due to metastatic disease. We present a rare case of
hepatic encephalopathy secondary to a massive deposit of
carcinoid tumour in the liver, with neurological recovery
following resection.
Case Report
A 42-year-old man presented with a two year history of
upper abdominal pain, cutaneous flushing, intermittent
watery diarrhoea and headaches. Over the preceding three
months he had suffered declining mental status, initially
characterised by forgetfulness, mild confusion, incoordina-
tion and irritability but ultimately progressing to somno-
lence, disorientation, marked deterioration in thought
processes and inappropriate behaviour that was at times
aggressive. Past medical history included hyperlipidaemia,
tobacco use and migraine headaches. There was no history
of diabetes, peripheral or coronary artery disease, intra-
venous drug or alcohol abuse, seizure disorder, head injury,
past liver disease, psychiatric disorder, psychoactive drug or
salicylate use, recent febrile illness, constipation or gas-
trointestinal haemorrhage.
On physical examination the patient appeared ill and
dishevelled but was well developed and adequately nour-
ished; he was somnolent but arousable, confused, disori-
ented and dysarthric. Vital signs were normal. The sclerae
were anicteric, the jugular veins flat, and the neck free of
bruits, masses or adenopathy. The lung sounds were normal
as were the cardiac and peripheral vascular examinations.
There was no gynaecomastia, palmar erythaema, spider
naevi, caput medusae or testicular atrophy. The abdomen
appeared moderately distended and was without signs of
ascites. A large, solid tumour was palpable in an enlarged
liver. Rectal examination was normal and the stool nega-
tive for occult blood. Neurological examination showed
asterixis, hypoactive deep tendon reflexes and ataxia but no
muscular rigidity.
Laboratory data revealed normal complete blood count,
serum electrolytes, arterial blood gas and thyroid function
studies. Serum toxicology screen was negative. The blood
urea was 3.9 mmol/L and creatinine 106.1 µmol/L. Liver
function tests were: aspartate aminotransferase 38 U/L
(normal 7–40), alanine aminotransferase 69 U/L (normal
6–53), alkaline phosphatase 107 U/L (normal 40–130),
lactate dehydrogenase 761 U/L (normal 300–620), total
bilirubin 15.4 µmol/L (normal 1.7–23.9 µmol),
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gamma–glutamyl transferase, 223 U/L (normal 10–88),
albumin 42 g/L (normal, 35–50), prothrombin time 13.0
seconds (11.9–14.5). Serum ammonia level was elevated at
235 µmol/L (normal 9–33 µmol/L), but alphafetoprotein
and carcinoembryonic antigen levels were normal. Twenty-
four-hour 5’–hydroxy–indolacetic acid (5’–HIAA) levels
were abnormally elevated at 77 mg/24 hours (normal
0.8–2.0).
Computed tomography (CT) scan of the head at the
referring hospital was normal. Hepatic ultrasound revealed
a large, solid hepatic mass that was further characterised by
CT scan as a 15 3 17 cm mass with compensatory left
hepatic lobe hypertrophy; there was no ascites,
splenomegaly or other intra-thoracic or abdominal pathol-
ogy (Figure 1). Search for a primary gastrointestinal carci-
noid tumour with contrast radiography and endoscopy was
unrevealing. Treatment was instituted for hepatic
encephalopathy including dietary protein restriction, oral
lactulose and oral neomycin. The serum ammonia level fell
to 70 µmol/L and was associated with improvement in
mental status. The intermittent flushing, headache and
right upper abdominal pain persisted, however. In the light
of a symptomatic hepatic mass that was probably secondary
to metastatic carcinoid tumour, the patient was prepared
for operation, with octreotide as prophylaxis against
carcinoid crisis.
The abdomen was explored through a bilateral sub-
costal incision. Massive hepatomegaly was identified with a
right hepatic lobe tumour extending into segment IV. The
left hepatic lobe was hypertrophied. Intraoperative ultra-
sound revealed tumour thrombus in the right and middle
hepatic veins (Figure 2). Ultrasound examination of the
pancreas was normal. Careful examination of the stomach,
small bowel, adrenal glands, spleen, colon, appendix and
intraperitoneal rectum revealed no gross pathology. An
extended right hepatic lobectomy was performed, and
histopathological examination was consistent with
metastatic neuroendocrine tumour. The patient’s recovery
was uncomplicated, and his mental status returned to nor-
mal together with serum ammonia levels and 24-hr urinary
5’–HIAA. He remains well and disease-free, three and a
half years later.
Discussion
Carcinoid tumours are derivatives of the amine precursor
uptake decarboxylation (APUD) neuroectodermal cell line
that oversecrete biologically active substances such as sero-
tonin. The carcinoid syndrome is characterised by inter-
mittent secretory diarrhoea, flushing, paroxysmal dyspnoea
and vasomotor instability. Neurological complications of
carcinoid tumours occur in 16% of patients and are most
frequently associated with widespread metastatic disease
(not unlike other systemic malignancies), which can cause
epidural spinal cord compression or deposits in the brain
and lepto-meninges [1].
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Figure 1. CT scan demonstrates massive tumour replacement of the right
liver.
Figure 2. Intraoperative ultrasound scan shows tumour thrombus in the
middle hepatic vein.
Non-metastatic neurological complications of carcinoid
tumours such as metabolic encephalopathy are rare (, 3%
in one large reported series) and typically occur with exten-
sive liver replacement and fulminant hepatic failure [1].
Hepatocellular dysfunction, particularly with marked
portosystemic shunting, results in excess accumulation of
unmetabolised ammonia. Other pathophysiological mecha-
nisms involved in hepatic encephalopathy include the
production of false neurotransmitters, altered cerebral
metabolism and endogenous activation of central nervous
system receptors for gamma–aminobutyric acid and
benzodiazepines [2]. Alterations in mental status in patients
with carcinoid syndrome have been attributed to a relative
deficiency of serotonin or its precursors in the central nerv-
ous system [3]. The clinical improvement following current
medical management of hepatic encephalopathy argues
against relative tryptophan, niacin or serotonin deficiency
as a cause of the neuropsychiatric syndrome seen in this
patient. The cause of his hepatic encephalopathy remains
elusive in the absence of hepatic failure.
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